Wonjin Effect

Automobiles US auto parts tariffs take effect; Korea avoids heavy hit

The US has eased tariffs on automotive parts that took effect on May 3, offering a sigh of relief to South Korean suppliers, who said a worst-case s...

Debt financing Korea debt financing faces woes as $34 bn in corporate bonds mature in H1

South Korea’s financial markets will see nearly 50 trillion won ($34 billion) in corporate bonds mature in the first half of next year —...

Business & Politics Ruthless Politics of South Korea Is Rooted in Cold-War History

.video-container {} .video-container { position:relative; aspect-ratio: 16/9; } .video-container iframe { width:100%; height:100%...

Shareholder activism Must Asset calls on Young Poong to take steps to boost shareholder value

South Korea’s Young Poong Corp., embroiled in a fierce management control dispute with Korea Zinc Inc., is now the target of an activist fund ...

Economy Korea’s household debt sees ‘balloon effect’ as rules tightened in Seoul

South Korea’s household lending market is witnessing a balloon effect as tighter government lending rules for Seoul and its surrounding metrop...

Robotics Samsung to unveil its first wearable robot Bot Fit by end-October

Samsung Electronics Co. will unveil its first wearable robot, Bot Fit, later this month as the South Korean tech giant delves into the global health...

Bio & Pharma Celltrion's Remsima SC breaks 20% market share in Europe

South Korea's biopharmaceutical company Celltrion Inc. said on Wednesday that its subcutaneous autoimmune disease treatment Remsima SC has surpassed...

Korean chipmakers Samsung's chip stockpile declines in Q4 2023

Samsung Electronics Co. has reported a decrease in its semiconductor inventory for the first time in 10 quarters, signaling a rebound in the memory ...

Batteries EcoPro partners with Cirba Solutions for battery recycling

South Korean battery materials manufacturer EcoPro Co. said on Thursday that it has signed a memorandum of understanding (MOU) with the US-based l...

Regulations South Korea Ban Takes Dog Meat Off the Menu

SEOUL—Dog meat will no longer be allowed in South Korea, capping a decadeslong campaign against a controversial practice that many locals have...

Short selling Korea’s top regulator detects more foreigners’ naked shorting

South Korea’s top financial regulator is detecting more circumstances of naked short-selling worth tens of millions of dollars by foreign inve...

Bio & Pharma ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe

ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...

Electronics Samsung to release Galaxy Book3 Go 5G laptop

Samsung Electronics Co. will release the Galaxy Book3 Go 5G laptop, which supports 5G networks on Jan. 2. Next year.The device features a 14-inch LC...

Asset management Barings taps John Park as S.Korean asset management head

Barings LLC has appointed Chong Hak (John) Park as head and sole representative director of its South Korean asset management arm, effective Jan. 1,...

Bio & Pharma Humedix gets gov't OK for trials of dementia candidate drug

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

Food & Beverage KFC Korea to start franchise business for faster growth

Fast food chain KFC said on Friday it will begin franchise store operations in South Korea next year, when the company will mark 40 years of busines...

Retail Emart partners with KOTRA to help S.Korean SMEs export

South Korea’s largest hypermarket chain Emart Inc. is partnering with Korea Trade-Investment Promotion Agency (KOTRA) to expand its overseas f...

Artificial intelligence Neurophet strives to be first mover in fight against Alzheimer’s

Neurophet Inc., a South Korean startup developing artificial intelligence-powered medical solutions for brain diseases, is striving to make a breakt...

Bio & Pharma AbClon shows promising results in clinical tests of leukemia treatment

South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...

Batteries POSCO Group plans talks with former US diplomat

Former US Deputy Secretary of State Stephen Biegun will hold talks with Chairman Choi Jeong-woo of South Korea’s POSCO Group.They will discuss...

Electronics Samsung Electro-Mechanics releases 200-megapixel camera module

South Korea's Samsung Electro-Mechanics on Monday announced its release of a smartphone camera module with 200 megapixels and double the shake reduc...

Bio & Pharma Daewoong Pharma's Fexuclue safe to use with aspirin: Clinical trials

Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...

Bio & Pharma HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China

South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...

Bio & Pharma Red ginseng prevents flu, pneumonia: research

Studies have shown that South Korea's hongsam (red ginseng) is effective in preventing respiratory diseases such as the flu and pneumonia.The Korean...

Bio & Pharma Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect

Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...

Chemical Industry Lotte Chemical conducts product risk assessment first time in Korea

Lotte Chemical Corp. said on Tuesday that it is conducting a risk assessment for its products for the first time in the domestic chemical industry...

Bio & Pharma NeoImmuneTech, US think tank to develop treatment for acute radiation syndrome

Biopharmaceutical company NeoImmuneTech has grabbed an opportunity to supply new drug candidates in development as strategic items to the US gover...

Bio & Pharma HLB confirms ophthalmic disease treatment in phase 3 clinical trials

South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...

Korean startups Silvia Health attracts investment through pre-Series A funding

Silvia Health Inc., an age-tech startup based in Seoul, South Korea said on Monday that it has completed a pre-Series A investment with the particip...

Bio & Pharma Medipost's Cartistem shows effects on patellar cartilage defect patients

Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...